Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Intangibles (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Intangibles for 11 consecutive years, with $696000.0 as the latest value for Q1 2026.

  • Quarterly Intangibles fell 24.18% to $696000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $696000.0 through Mar 2026, down 24.18% year-over-year, with the annual reading at $751000.0 for FY2025, 22.9% down from the prior year.
  • Intangibles for Q1 2026 was $696000.0 at Achieve Life Sciences, down from $751000.0 in the prior quarter.
  • The five-year high for Intangibles was $1.6 million in Q1 2022, with the low at $696000.0 in Q1 2026.
  • Average Intangibles over 5 years is $1.1 million, with a median of $1.1 million recorded in 2024.
  • The widest YoY moves for Intangibles: up 12.33% in 2022, down 50.91% in 2022.
  • Achieve Life Sciences' Intangibles stood at $1.4 million in 2022, then decreased by 15.59% to $1.2 million in 2023, then fell by 18.63% to $974000.0 in 2024, then fell by 22.9% to $751000.0 in 2025, then dropped by 7.32% to $696000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Intangibles are $696000.0 (Q1 2026), $751000.0 (Q4 2025), and $807000.0 (Q3 2025).